FDA inspection
Zhejiang Xianju Junye Pharmaceutical Co., Ltd.: FDA inspection ending Jan 11, 2019
FDA inspection 1080056 · No Action Indicated (NAI) · Taizhou
Key facts
| Inspection ID | 1080056 |
|---|---|
| Firm | Zhejiang Xianju Junye Pharmaceutical Co., Ltd. |
| FEI number | 3004072297 |
| Address | No. 1 Lingxiu Road, Modern Centralization Zone |
| City | Taizhou |
| Country | China |
| Fiscal year | 2019 |
| Inspection end date | Jan 11, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data